Abstract
A simple method for the synthesis of magnetic hollow silica microspheres is reported. Magnetic hollow silica was obtained after pretreating via precipitation method of the dextran template microspheres with magnetite. Silica shell was obtained from Na2SiO3. After thermal decomposition of the dextran template, the magnetic silica shells remained intact, as demonstrated by SEM and no evidence of dextran remnants was found according to FT-IR spectra. XRD patterns showed the formation of well-crystallized Fe3O4 and Fe2O3, even if the silica presence can be identified by FT-IR, XRD spectrum do not exhibit the formation of SiO2 network because of the very low degree of cristallinity. This material has been prepared in order to develop a magnetic drug delivery system that can be used to facilitate the targeted drug delivery of antibiotics, by testing the comparative antimicrobial activity of antibiotics themselves as well as loaded into the magnetic hollows against the suspended microbial cells. Citotoxicity studies have been carried on for the new materials by using tripan blue staining technique and eukaryotic cell cycle analysis. The obtained magnetic hollows proved to exhibit low citotoxicity levels on the HCT8 standardized cell line. The antimicrobial susceptibility assay revealed an improvement of the antimicrobial activity of the tested antibiotics on S. aureus, but not on E. coli strain. These results are demonstrating the potential use of the obtained microspheres as biocompatible antibiotic delivery and/or controlled release systems with. However, their efficiency seems to be dependent on the antibiotic structure as well as on the tested microbial strain.
Keywords: Hollow silica, Core/shell, Magnetic hollow, Drug delivery, MIC.
Current Organic Chemistry
Title:Biocompatible Magnetic Hollow Silica Microspheres for Drug Delivery
Volume: 17 Issue: 10
Author(s): Alexandru M. Grumezescu, Ecaterina Andronescu, Anton Ficai, Valentina Grumezescu, Coralia Bleotu, Crina Saviuc, Dan Eduard Mihaiescu and Carmen M. Chifiriuc
Affiliation:
Keywords: Hollow silica, Core/shell, Magnetic hollow, Drug delivery, MIC.
Abstract: A simple method for the synthesis of magnetic hollow silica microspheres is reported. Magnetic hollow silica was obtained after pretreating via precipitation method of the dextran template microspheres with magnetite. Silica shell was obtained from Na2SiO3. After thermal decomposition of the dextran template, the magnetic silica shells remained intact, as demonstrated by SEM and no evidence of dextran remnants was found according to FT-IR spectra. XRD patterns showed the formation of well-crystallized Fe3O4 and Fe2O3, even if the silica presence can be identified by FT-IR, XRD spectrum do not exhibit the formation of SiO2 network because of the very low degree of cristallinity. This material has been prepared in order to develop a magnetic drug delivery system that can be used to facilitate the targeted drug delivery of antibiotics, by testing the comparative antimicrobial activity of antibiotics themselves as well as loaded into the magnetic hollows against the suspended microbial cells. Citotoxicity studies have been carried on for the new materials by using tripan blue staining technique and eukaryotic cell cycle analysis. The obtained magnetic hollows proved to exhibit low citotoxicity levels on the HCT8 standardized cell line. The antimicrobial susceptibility assay revealed an improvement of the antimicrobial activity of the tested antibiotics on S. aureus, but not on E. coli strain. These results are demonstrating the potential use of the obtained microspheres as biocompatible antibiotic delivery and/or controlled release systems with. However, their efficiency seems to be dependent on the antibiotic structure as well as on the tested microbial strain.
Export Options
About this article
Cite this article as:
Grumezescu M. Alexandru, Andronescu Ecaterina, Ficai Anton, Grumezescu Valentina, Bleotu Coralia, Saviuc Crina, Mihaiescu Eduard Dan and Chifiriuc M. Carmen, Biocompatible Magnetic Hollow Silica Microspheres for Drug Delivery, Current Organic Chemistry 2013; 17 (10) . https://dx.doi.org/10.2174/1385272811317100005
DOI https://dx.doi.org/10.2174/1385272811317100005 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis
Current Pharmaceutical Design Different Treatment Strategies for Pediatric Brain Tumors
Current Pediatric Reviews Regulation of Breast Cancer Progression by Noncoding RNAs
Current Cancer Drug Targets Virotherapy as An Approach Against Cancer Stem Cells
Current Gene Therapy Editor’s Perspective: Metabolomics Currently
Current Metabolomics Interleukin-21 (IL-21) Controls Inflammatory Pathways in the Gut
Endocrine, Metabolic & Immune Disorders - Drug Targets Anti-Apoptotic Actions of Insulin-Like Growth Factors: Lessons from Development and Implications in Neoplastic Cell Transformation
Current Pharmaceutical Design Application of Genetic Polymorphisms in DNA Repair in the Prediction of Cancer Susceptibility and Clinical Outcome
Current Pharmacogenomics Erythropoietin in Cancer: An Update
Current Molecular Medicine Insulin-Like Growth Factor 2 - The Oncogene and its Accomplices
Current Pharmaceutical Design Tyrosine Kinase Inhibitors: A Potential Approach to the Treatment of Hepatocellular Carcinoma
Current Pharmaceutical Design Obesity Modulation - The Role in Carcinogenesis
Anti-Cancer Agents in Medicinal Chemistry Mucin-based Targeted Pancreatic Cancer Therapy
Current Pharmaceutical Design In Vivo Target Validation: Methodology and Case Studies on the Janus Kinase Tyk2
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Prodrug Design of Phenolic Drugs
Current Pharmaceutical Design Editorial [Hot topic: Target Therapy of Bone Metastases and Tumours (Guest Editors: M. Caraglia and D. Santini)]
Current Cancer Drug Targets Prevention of Ischemic Stroke: Antithrombotic Therapy in Cardiac Embolism
Current Drug Targets MicroRNA Therapeutics in Neurological Disease
Current Pharmaceutical Design Resveratrol-Mediated Reversal of Tumor Multi-Drug Resistance
Current Drug Metabolism Single-Photon Emission Computed Tomography Tracers for Predicting and Monitoring Cancer Therapy
Current Pharmaceutical Biotechnology